|
1
|
Hutson TE and Quinn DI: Cytokine therapy:
a standard of care for metastatic renal cell carcinoma? Clin
Genitourin Cancer. 4:181–186. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thoenes W, Störkel S and Rumpelt HJ:
Histopathology and classification of renal cell tumors (adenomas,
oncocytomas and carcinomas). The basic cytological and
histopathological elements and their use for diagnostics. Pathol
Res Pract. 181:125–143. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Al Otaibi M, Abou Youssif T, Alkhaldi A,
Sircar K, Kassouf W, Aprikian A, Mulder D and Tanguay S: Renal cell
carcinoma with inferior vena caval extention: impact of tumour
extent on surgical outcome. BJU In. 104:1467–70. 2009.PubMed/NCBI
|
|
4
|
Choueiri TK, Garcia JA, Elson P, Khasawneh
M, Usman S, Golshayan AR, Baz RC, Wood L, Rini BI and Bukowski RM:
Clinical factors associated with outcome in patients with
metastatic clear-cell renal cell carcinoma treated with vascular
endothelial growth factor-targeted therapy. Cancer. 110:543–550.
2007. View Article : Google Scholar
|
|
5
|
Amato RJ: Chemotherapy for renal cell
carcinoma. Semin Oncol. 27:177–186. 2000.PubMed/NCBI
|
|
6
|
Yagoda A, Abi-Rached B and Petrylak D:
Chemotherapy for advanced renal-cell carcinoma: 1983–1993. Semin
Oncol. 22:42–60. 1995.
|
|
7
|
Cohen HT and McGovern FJ: Renal-cell
carcinoma. N Engl J Med. 353:2477–2490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brugarolas J: Renal-cell
carcinoma-molecular pathways and therapies. N Engl J Med.
356:185–187. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Athar U and Gentile TC: Treatment options
for metastatic renal cell carcinoma: a review. Can J Urol.
15:3954–3966. 2008.PubMed/NCBI
|
|
10
|
Liu YH, Li ML, Hsu MY, et al: Effects of a
Chinese herbal medicine, guan-jen-huang (Aeginetia Indica
Linn.), on renal cancer cell growth and metastasis. Evid Based
Complement Alternat Med. 2012:9358602012.PubMed/NCBI
|
|
11
|
Wang SC, Tang SW, Lam SH, et al: Aqueous
extract of Paeonia suffruticosa inhibits migration and
metastasis of renal cell carcinoma cells via suppressing VEGFR-3
pathway. Evid Based Complement Alternat Med.
2012:4098232012.PubMed/NCBI
|
|
12
|
Lee SK, Jung HS, Eo WK, Lee SY, Kim SH and
Shim BS: Rhus verniciflua Stokes extract as a potential
option for treatment of metastatic renal cell carcinoma: report of
two cases. Ann Oncol. 21:1383–1385. 2010. View Article : Google Scholar
|
|
13
|
Lin CY, Chen PN, Hsieh YS and Chu SC:
Koelreuteria formosana extract impedes in vitro human LDL and
prevents oxidised LDL induced apoptosis in human umbilical vein
endothelial cells. Food Chem. 146:299–307. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Abou Shoer M, Ma GE, Li XH, Koonchanok NM,
Geahlen RL and Chang CJ: Flavonoids from Koelreuteria henryi and
other sources as protein tyrosine kinase inhibitors. J Nat Prod.
56:967–969. 1993.
|
|
15
|
Chang CJ, Ashendel CL, Geahlen RL,
McLaughlin JL and Waters DJ: Oncogene signal transduction
inhibitors from medicinal plants. In Vivo. 10:185–190.
1996.PubMed/NCBI
|
|
16
|
Lee TH, Chiang YH, Chen CH, Chen PY and
Lee CK: A new flavonol galloylrhamnoside and a new lignan glucoside
from the leaves of Koelreuteria henryi Dummer. J Nat Med.
63:209–214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abou-Shoer M, Ma GE, Li XH, Koonchanok NM,
Geahlen RL and Chang CJ: Flavonoids from Koelreuteria henryi
and other sources as protein-tyrosine kinase inhibitors. J Nat
Prod. 56:967–969. 1993.
|
|
18
|
Song YN, Zhang HL, Chang CJ and Bollag DM:
Cytotoxic cyclolignans from Koelreuteria henryi. J Nat Prod.
57:1670–1674. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen CH, Chan HC, Chu YT, et al:
Antioxidant activity of some plant extracts towards xanthine
oxidase, lipoxygenase and tyrosinase. Molecules. 14:2947–2958.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin CY, Chen PN, Hsieh YS and Chu SC:
Koelreuteria formosana extract impedes in vitro human LDL
and prevents oxidised LDL-induced apoptosis in human umbilical vein
endothelial cells. Food Chem. 146:299–307. 2014. View Article : Google Scholar
|
|
21
|
Ho ML, Hsieh YS, Chen JY, Chen KS, Chen
JJ, Kuo WH, Lin SJ and Chen PN: Antimetastatic potentials of
Dioscorea nipponica on Melanoma in vitro and in vivo. Food
Chem Toxicol. 50:558–66. 2012.
|
|
22
|
Chu SC, Chiou HL, Chen PN, Yang SF and
Hsieh YS: Silibinin inhibits the invasion of human lung cancer
cells via decreased productions of urokinase-plasminogen activator
and matrix metalloproteinase-2. Mol Carcinog. 40:143–149. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen PN, Hsieh YS, Chiang CL, Chiou HL,
Yang SF and Chu SC: Silibinin inhibits invasion of oral cancer
cells by suppressing the MAPK pathway. J Dent Res. 85:220–225.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chu SC, Yang SF, Liu SJ, Kuo WH, Chang YZ
and Hsieh YS: In vitro and in vivo antimetastatic effects of
Terminalia catappa L. leaves on lung cancer cells. Food Chem
Toxicol. 45:1194–1201. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim HJ, Kim YM, Lim S, et al: Ubiquitin
C-terminal hydrolase-L1 is a key regulator of tumor cell invasion
and metastasis. Oncogene. 28:117–127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lo C, Lai TY, Yang JS, et al: Gallic acid
inhibits the migration and invasion of A375.S2 human melanoma cells
through the inhibition of matrix metalloproteinase-2 and Ras.
Melanoma Res. 21:267–273. 2011. View Article : Google Scholar
|
|
27
|
Ho HH, Chang CS, Ho WC, Liao SY, Wu CH and
Wang CJ: Anti-metastasis effects of gallic acid on gastric cancer
cells involves inhibition of NF-kappaB activity and downregulation
of PI3K/AKT/small GTPase signals. Food Chem Toxicol. 48:2508–2516.
2010. View Article : Google Scholar
|
|
28
|
Peng CY, Yang HW, Chu YH, et al: Caffeic
acid phenethyl ester inhibits oral cancer cell metastasis by
regulating matrix metalloproteinase-2 and the mitogen-activated
protein kinase pathway. Evid Based Complement Alternat Med.
2012:7325782012.PubMed/NCBI
|
|
29
|
Chung TW, Moon SK, Chang YC, et al: Novel
and therapeutic effect of caffeic acid and caffeic acid phenyl
ester on hepatocarcinoma cells: complete regression of hepatoma
growth and metastasis by dual mechanism. FASEB J. 18:1670–1681.
2004. View Article : Google Scholar
|
|
30
|
Noel A, Maillard C, Rocks N, Jost M,
Chabottaux V, Sounni NE, Maquoi E, Cataldo D and Foidart JM:
Membrane associated proteases and their inhibitors in tumour
angiogenesis. J Clin Pathol. 57:577–584. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kawata N, Nagane Y, Hirakata H, et al:
Significant relationship of matrix metalloproteinase 9 with nuclear
grade and prognostic impact of tissue inhibitor of
metalloproteinase 2 for incidental clear cell renal cell carcinoma.
Urology. 69:1049–1053. 2007. View Article : Google Scholar
|
|
32
|
Takahashi M, Oka N, Naroda T, et al:
Prognostic significance of matrix metalloproteinases-2 activation
ratio in renal cell carcinoma. Int J Urol. 9:531–538. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Harada K, Sakai I, Ishimura T, Inoue TA,
Hara I and Miyake H: Clinical symptoms in localized renal cell
carcinoma reflect its invasive potential: comparative study between
incidentally detected and symptomatic diseases. Urol Oncol.
24:201–206. 2006. View Article : Google Scholar
|
|
34
|
Kallakury BV, Karikehalli S, Haholu A,
Sheehan CE, Azumi N and Ross JS: Increased expression of matrix
metalloproteinases 2 and 9 and tissue inhibitors of
metalloproteinases 1 and 2 correlate with poor prognostic variables
in renal cell carcinoma. Clin Cancer Res. 7:3113–3119.
2001.PubMed/NCBI
|
|
35
|
Liu KC, Huang AC, Wu PP, et al: Gallic
acid suppresses the migration and invasion of PC-3 human prostate
cancer cells via inhibition of matrix metalloproteinase-2 and -9
signaling pathways. Oncol Rep. 26:177–184. 2011.PubMed/NCBI
|
|
36
|
Huang Z, Yan DP and Ge BX: JNK regulates
cell migration through promotion of tyrosine phosphorylation of
paxillin. Cell Signal. 20:2002–2012. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chang HR, Chen PN, Yang SF, et al:
Silibinin inhibits the invasion and migration of renal carcinoma
786-O cells in vitro, inhibits the growth of xenografts in vivo and
enhances chemosensitivity to 5-fluorouracil and paclitaxel. Mol
Carcinog. 50:811–823. 2011. View
Article : Google Scholar
|
